Polycyclic aromatic hydrocarbons and childhood asthma

Parisa Karimi1, Kamau O Peters, Katayoon Bidad

  • 1Program in Occupational and Environmental Health, Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Room E7535, Baltimore, MD, USA.

Insights

Childhood asthma is a growing concern, linked to factors like tobacco smoke and urban living. New research explores how polycyclic aromatic hydrocarbons (PAHs) from pollution may increase asthma risk and severity in children.

Area of Science:

  • Environmental Health
  • Pediatric Medicine
  • Respiratory Medicine

Background:

  • Asthma is a prevalent chronic childhood illness, causing significant hospitalizations and school absences.
  • Increasing asthma prevalence shows disparities across demographics and geographic locations.
  • Known risk factors include genetics, allergies, environmental exposures like tobacco smoke, and lifestyle factors.

Purpose of the Study:

  • To review the sources of childhood exposure to polycyclic aromatic hydrocarbons (PAHs).
  • To examine the association between airborne PAH exposure and childhood asthma prevalence.
  • To investigate the link between PAH exposure and asthma exacerbation in children.

Main Methods:

  • Literature review of studies on childhood asthma and PAH exposure.
  • Analysis of data linking environmental PAH sources to asthma incidence.
  • Examination of research on PAH exposure and asthma symptom severity.

Main Results:

  • Polycyclic aromatic hydrocarbons (PAHs), common in air pollution, are increasingly linked to asthma onset.
  • Airborne PAH exposure is associated with higher rates of childhood asthma.
  • PAH exposure correlates with increased frequency and severity of asthma exacerbations in children.

Conclusions:

  • Childhood asthma is a complex condition influenced by various factors, including environmental pollutants.
  • Exposure to polycyclic aromatic hydrocarbons (PAHs) represents a significant environmental risk factor for childhood asthma.
  • Further research is warranted to understand and mitigate the impact of PAHs on pediatric respiratory health.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
3
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.8K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
5.0K
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
2
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
2
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K